Search results

Researchers and industry partners from UNSW Australia, the Australian Centre for Nanomedicine, Children’s Cancer Institute and Inventia Life Sciences Pty Ltd have been awarded the 2021 ANSTO Eureka Prize for Innovative Use of Technology for their method to rapidly-produce 3D cell structures

Australia’s Open Pool Australian Lightwater (OPAL) reactor is a state-of-the-art 20 megawatt multi-purpose reactor that uses low enriched uranium (LEU) fuel to achieve a range of  activities to benefit human health, enable research to support a more sustainable environment and provide innovative solutions for industry.

CORIS360® GNI images gamma-ray and thermal neutron radiation sources, delivering an unprecedented ability to detect, localise, and identify nuclear materials.

ANSTO is a partner on the National Space Qualification Network (NSQN) led by the Australian National University (ANU) that will transform Australia into a world-leading space centre by enhancing facilities to test payloads, components, and hardware prior to their use in harsh environments of space.

Over the past 70 years ANSTO has been building Australia’s nuclear expertise and despite being small in scale, today we are complex and sophisticated nuclear nation.

ANSTO is taking its innovative ANSTO Synroc® and CORIS360® technologies to the world stage at the Waste Management Symposia 2024 in Phoenix, Arizona USA this week (10 – 14 March 2024). Joining over 45 other countries and around 3,000 attendees, an Australian Government contingent comprising of ANSTO and the Australian Radioactive Waste Agency is in attendance to showcase Australia’s extensive radioactive waste management capabilities.

ANSTO is a unique national science organisation that began operating under its predecessor The Australian Atomic Energy Commission (AAEC) 70 years ago.

Three ANSTO scientists are contributing to two recently awarded Australian Research Council Discovery Project grants.

ANSTO’s user office in Melbourne offers access to the Australian Synchrotron, a world-class research facility with over 4,000 user visits per year. ANSTO seeks collaboration and partnerships with research organisations, scientific users and commercial users.

The National Deuteration Facility is providing deuterated cholesterol, an essential ingredient in lipid nanoparticles for the delivery of vaccines using mRNA, to academic and industry partners.

Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia

ANSTO recognised the contribution of individuals and teams to nuclear science and technology at the 2023 ANSTO Awards Ceremony held on 25 July.

The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.

The Imaging and Medical beamline (IMBL) is a flagship beamline of the Australian Synchrotron built with considerable support from the NHMRC. It is one of only a few of its type, and delivers the world’s widest synchrotron x-ray ‘beam’.

Highlights of the Energy Materials Project.